Myelosuppression of thrombocytes and monocytes is associated with a lack of synergy between chemotherapy and anti-VEGF treatment. [electronic resource]
Producer: 20111031Description: 419-27 p. digitalISSN:- 1476-5586
- Adult
- Aged
- Aged, 80 and over
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Humanized
- Bevacizumab
- Blood Platelets -- cytology
- Bone Marrow -- drug effects
- Cell Movement
- Chemokine CXCL12 -- blood
- Deoxycytidine -- analogs & derivatives
- Drug Synergism
- Female
- Humans
- Leukocyte Count
- Male
- Middle Aged
- Monocytes -- cytology
- Neoadjuvant Therapy
- Neovascularization, Physiologic -- drug effects
- Pancreatic Neoplasms -- drug therapy
- Stem Cells -- cytology
- Thrombocytopenia
- Treatment Outcome
- Vascular Endothelial Growth Factor A -- antagonists & inhibitors
- Gemcitabine
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.